Cardiovascular and Metabolic Disorders

Latest News

Statins Reduce MACE in Diabetes Without Obstructive CAD

By

Endocrinology Advisor Contributing Writer

The researchers studied the effect of aspirin and statin treatment on cardiovascular and bleeding incidence in patients with diabetes in the absence of obstructive CAD.

Bariatric Surgery Reduces ICP in Women With Obesity and Intracranial Hypertension

By

Brandon May

Investigators compared bariatric surgery with a community weight management intervention in ability to reduce intracranial pressure among patients with idiopathic intracranial hypertension.

Digital Intervention Improves Depression With Comorbid Hypertension, Diabetes Over Short Term

By

Emily Pond

The researchers studied the effectiveness of a digital intervention in reducing depressive symptoms among patients with diabetes and/or hypertension.

AHA/ASA 2021 Guidelines for Secondary Stroke Prevention

By

Endocrinology Advisor Contributing Writer

Here are highlights from the American Heart Association and American Stroke Association’s 2021 evidence-based guidelines for preventing another stroke after a first stroke or transient ischemic attack.

Switching to Plant Protein for Dinner May Reduce CVD Risk

Overconsuming low-quality carbohydrates and animal protein at dinner versus breakfast is associated with a significantly increased risk for cardiovascular disease.

Study Finds Liver Fibrosis to be an Independent Predictor of Diabetic Peripheral Neuropathy

By

Jessica Nye, PhD

Researchers evaluated the correlation of liver fibrosis and steatosis with diabetic peripheral neuropathy in patients with type 2 diabetes.

CDC Investigating Heart Problems in Teens, Young Adults After COVID-19 Vaccination

Reports of myocarditis in a small number of teens and young adults who have received COVID-19 vaccines are being investigated by the CDC.

ACC: Fish Oil Does Not Improve Outcomes for Those at High CV Risk

High levels of eicosapentaenoic acid, an omega-3 atty acid, are no benefit to patients at high risk for cardiovascular events.

Dysrhythmias in Patients With COVID-19

By

Deedra Harrington, DNP, MSN, APRN, ACNP-BC

Frances Stueben, DNP, RN, CHSE

Christy L. McDonald Lenahan, DNP, FNP-BC, ENP-C, CNE

Sinus tachycardia is the most commonly reported dysrhythmia in patients with COVID-19 disease.

SGLT2i Use Linked to Reduced Cardiac Arrhythmia Risk

By

Endocrinology Advisor Contributing Writer

Sodium-glucose cotransporter 2 inhibitors use may reduce cardiac arrhythmia risk, including the risk for atrial fibrillation.

Inequities in Hypertension Care Magnified by the COVID-19 Pandemic

By

Jessica Nye, PhD

The COVID-19 epidemic has highlighted disparities in hypertension control in the United States.